Ibrutinib Dosing Strategies Based on Interaction Potential of CYP3A4 Perpetrators Using Physiologically Based Pharmacokinetic Modeling
de Zwart, L, Snoeys, J, De Jong, J, Sukbuntherng, J, Mannaert, E, Monshouwer, M
Published in Clinical pharmacology and therapeutics (01.11.2016)
Published in Clinical pharmacology and therapeutics (01.11.2016)
Get more information
Journal Article
A survey on IVIVC/IVIVR development in the pharmaceutical industry – Past experience and current perspectives
Nguyen, M.A., Flanagan, T., Brewster, M., Kesisoglou, F., Beato, S., Biewenga, J., Crison, J., Holm, R., Li, R., Mannaert, E., McAllister, M., Mueller-Zsigmondy, M., Muenster, U., Ojala, K., Page, S., Parr, A., Rossenu, S., Timmins, P., Van Peer, A., Vermeulen, A., Langguth, P.
Published in European journal of pharmaceutical sciences (01.05.2017)
Published in European journal of pharmaceutical sciences (01.05.2017)
Get full text
Journal Article
Pharmacokinetic profile of long-acting injectable risperidone at steady-state: comparison with oral administration
Mannaert, E, Vermeulen, A, Remmerie, B, Bouhours, P, Levron, J C
Published in Encéphale (01.09.2005)
Published in Encéphale (01.09.2005)
Get more information
Journal Article
Pharmacokinetics and safety of combination therapy with lithium and risperidone
Demling, J H, Huang, M-L, Remmerie, B, Mannaert, E, Sperling, W
Published in Pharmacopsychiatry (01.11.2006)
Published in Pharmacopsychiatry (01.11.2006)
Get more information
Journal Article
Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia
Eerdekens, Mariëlle, Van Hove, Ilse, Remmerie, Bart, Mannaert, Erik
Published in Schizophrenia research (01.09.2004)
Published in Schizophrenia research (01.09.2004)
Get full text
Journal Article
A PET Study Evaluating Dopamine D 2 Receptor Occupancy for Long-Acting Injectable Risperidone
Remington, Gary, Mamo, David, Labelle, Alain, Reiss, Jeffrey, Shammi, Chekkera, Mannaert, Erik, Mann, Steve, Kapur, Shitij
Published in The American journal of psychiatry (01.03.2006)
Published in The American journal of psychiatry (01.03.2006)
Get full text
Journal Article
Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta™) in patients with schizophrenia
Gefvert, Ola, Eriksson, Bo, Persson, Per, Helldin, Lars, Björner, Annika, Mannaert, Erik, Remmerie, Bart, Eerdekens, Mariëlle, Nyberg, Svante
Published in The international journal of neuropsychopharmacology (01.03.2005)
Published in The international journal of neuropsychopharmacology (01.03.2005)
Get full text
Journal Article
D2-receptor occupancies and corresponding plasma concentrations: a comparison of paliperidone extended-release (ER) with risperidone immediate-release (IR)
Rossenu, S, Mannaert, E, Hargarter, L, Mehnert, A, Vermeulen, A
Published in Pharmacopsychiatry (01.09.2009)
Published in Pharmacopsychiatry (01.09.2009)
Get full text
Conference Proceeding
Effect of renal impairment on the pharmacokinetics of prucalopride: a single- dose open-label Phase I study
Smith, William B, Mannaert, Erik, Verhaeghe, Tom, Kerstens, René, Vandeplassche, Lieve, Van de Velde, Vera
Published in Drug design, development and therapy (01.01.2012)
Published in Drug design, development and therapy (01.01.2012)
Get full text
Journal Article
Pharmacokinetic comparison of fast-disintegrating and conventional tablet formulations of risperidone in healthy volunteers
van Schaick, Erno A., Lechat, Philippe, Remmerie, Bart M.M., Ko, Grant, Lasseter, Kenneth C., Mannaert, Erik
Published in Clinical therapeutics (01.06.2003)
Published in Clinical therapeutics (01.06.2003)
Get full text
Journal Article
P.2.034 A novel fast-disintegrating oral formulation of the atypical antipsychotic resperidone
Mintzer, J., Lechat, P.H., Remmerie, B., Mannaert, E.
Published in European neuropsychopharmacology (01.10.2003)
Published in European neuropsychopharmacology (01.10.2003)
Get full text
Journal Article
Pharmacokinetics and dopamine d2 and serotonin 5-ht2a receptor occupancy of paliperidone in healthy subjects: two open-label, single-dose studies (PAL-115)
Karlsson, P, Hargarter, L, Dencker, E, Nyberg, S, Mannaert, E, Boom, S, Talluri, K, Rossenu, S, Eriksson, B, Eerdekens, M, Farde, L
Published in Pharmacopsychiatry (08.10.2007)
Published in Pharmacopsychiatry (08.10.2007)
Get full text
Conference Proceeding